248 related articles for article (PubMed ID: 2527229)
1. Butanedione monoxime suppresses contraction and ATPase activity of rabbit skeletal muscle.
Higuchi H; Takemori S
J Biochem; 1989 Apr; 105(4):638-43. PubMed ID: 2527229
[TBL] [Abstract][Full Text] [Related]
2. Effect of 2,3-butanedione monoxime on myosin and myofibrillar ATPases. An example of an uncompetitive inhibitor.
Herrmann C; Wray J; Travers F; Barman T
Biochemistry; 1992 Dec; 31(48):12227-32. PubMed ID: 1457420
[TBL] [Abstract][Full Text] [Related]
3. The influence of 2,3-butanedione 2-monoxime (BDM) on the interaction between actin and myosin in solution and in skinned muscle fibres.
McKillop DF; Fortune NS; Ranatunga KW; Geeves MA
J Muscle Res Cell Motil; 1994 Jun; 15(3):309-18. PubMed ID: 7929796
[TBL] [Abstract][Full Text] [Related]
4. Suppressing effect of 2,3-butanedione monoxime on contraction and ATPase activity of rabbit skeletal muscle.
Higuchi H; Takemori S; Umazume Y
Prog Clin Biol Res; 1989; 315():225-6. PubMed ID: 2529562
[No Abstract] [Full Text] [Related]
5. Effects of 2,3-butanedione monoxime on contraction of frog skeletal muscles: an X-ray diffraction study.
Yagi N; Takemori S; Watanabe M; Horiuti K; Amemiya Y
J Muscle Res Cell Motil; 1992 Apr; 13(2):153-60. PubMed ID: 1534565
[TBL] [Abstract][Full Text] [Related]
6. Detachment of low-force bridges contributes to the rapid tension transients of skinned rabbit skeletal muscle fibres.
Seow CY; Shroff SG; Ford LE
J Physiol; 1997 May; 501 ( Pt 1)(Pt 1):149-64. PubMed ID: 9175000
[TBL] [Abstract][Full Text] [Related]
7. Mechanism of action of 2, 3-butanedione 2-monoxime on contraction of frog skeletal muscle fibres.
Horiuti K; Higuchi H; Umazume Y; Konishi M; Okazaki O; Kurihara S
J Muscle Res Cell Motil; 1988 Apr; 9(2):156-64. PubMed ID: 2458382
[TBL] [Abstract][Full Text] [Related]
8. [Non-specific effect of myosin inhibitor BDM on skeletal muscle contractile function].
Yu ZB; Gao F
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2005 Nov; 21(4):449-52. PubMed ID: 21180172
[TBL] [Abstract][Full Text] [Related]
9. Effects of 2,3-butanedione monoxime on the contractile activation properties of fast- and slow-twitch rat muscle fibres.
Fryer MW; Neering IR; Stephenson DG
J Physiol; 1988 Dec; 407():53-75. PubMed ID: 3256625
[TBL] [Abstract][Full Text] [Related]
10. The effects of 2,3-butanedione monoxime on initial heat, tension, and aequorin light output of ferret papillary muscles.
Blanchard EM; Smith GL; Allen DG; Alpert NR
Pflugers Arch; 1990 Apr; 416(1-2):219-21. PubMed ID: 2352836
[TBL] [Abstract][Full Text] [Related]
11. Interplay of troponin- and Myosin-based pathways of calcium activation in skeletal and cardiac muscle: the use of W7 as an inhibitor of thin filament activation.
Adhikari BB; Wang K
Biophys J; 2004 Jan; 86(1 Pt 1):359-70. PubMed ID: 14695278
[TBL] [Abstract][Full Text] [Related]
12. Effects of butanedione monoxime on neuromuscular transmission.
Gage PW; McArdle JJ; Saint DA
Br J Pharmacol; 1990 Jul; 100(3):467-70. PubMed ID: 1975206
[TBL] [Abstract][Full Text] [Related]
13. BDM (2,3-butanedione monoxime), an inhibitor of myosin-actin interaction, suppresses myofibrillogenesis in skeletal muscle cells in culture.
Soeno Y; Shimada Y; Obinata T
Cell Tissue Res; 1999 Feb; 295(2):307-16. PubMed ID: 9931377
[TBL] [Abstract][Full Text] [Related]
14. Muscle cross-bridges bound to actin are disordered in the presence of 2,3-butanedione monoxime.
Zhao L; Naber N; Cooke R
Biophys J; 1995 May; 68(5):1980-90. PubMed ID: 7612840
[TBL] [Abstract][Full Text] [Related]
15. Paralysis of skeletal muscle by butanedione monoxime, a chemical phosphatase.
Fryer MW; Gage PW; Neering IR; Dulhunty AF; Lamb GD
Pflugers Arch; 1988 Jan; 411(1):76-9. PubMed ID: 2832824
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the cross-bridge force-generating step using inorganic phosphate and BDM in myofibrils from rabbit skeletal muscles.
Tesi C; Colomo F; Piroddi N; Poggesi C
J Physiol; 2002 May; 541(Pt 1):187-99. PubMed ID: 12015429
[TBL] [Abstract][Full Text] [Related]
17. Ca2+ and Sr2+ activation: comparison of cardiac and skeletal muscle contraction models.
Kerrick WG; Malencik DA; Hoar PE; Potter JD; Coby RL; Pocinwong S; Fischer EH
Pflugers Arch; 1980 Aug; 386(3):207-13. PubMed ID: 6448403
[TBL] [Abstract][Full Text] [Related]
18. 2,3-Butanedione monoxime (BDM) as a myosin inhibitor.
Ostap EM
J Muscle Res Cell Motil; 2002; 23(4):305-8. PubMed ID: 12630704
[TBL] [Abstract][Full Text] [Related]
19. The effect of 2,3-butanedione monoxime (BDM) on smooth muscle mechanical properties.
Packer CS; Kagan ML; Kagan JF; Robertson SA; Stephens NL
Pflugers Arch; 1988 Oct; 412(6):659-64. PubMed ID: 3211716
[TBL] [Abstract][Full Text] [Related]
20. Effects of 2,3-butanedione 2-monoxime on Ca2+ release channels (ryanodine receptors) of cardiac and skeletal muscle.
Tripathy A; Xu L; Pasek DA; Meissner G
J Membr Biol; 1999 Jun; 169(3):189-98. PubMed ID: 10354465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
